Everyone has heard of insider trading, but what is it really? Essentially, as an “insider,” you are not allowed to make beneficial trades unfairly. To prove insider trading, the federal government must show that the information was embargoed or confidential prior to the execution of the trade.
In this case, a Chicago physician is being accused of purchasing shares of a California-based biotech company that recently announced positive results of a new cancer treatment. The physician is accused of making the trade before the company announced the results publicly. Hence, insider trading.
According to federal prosecutors, the defendant used his position to acquire confidential information that was embargoed for public disclosure. He then used that information to make a trade prior to the announcement of a major success and is now accused of insider trading. Federal prosecutors accuse the doctor of making $134,000 off the illegal trade, purchasing over 8,000 shares and then selling them shortly after the announcement.